Current drug delivery · 2026
pH-responsive Nanomedicine Delivery Platform Based on Silicon Nanoparticles for Imaging and Photodynamic Therapy of Tumor Cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Jiahui, Zhang Yihao, Hao Changan, Chen Zhaoqian, Yang Yiting, Dou Yakun
Аннотация
INTRODUCTION: Fluorescent silicon nanoparticles (Si NPs) are attractive bioimaging probes, but their emission is mainly confined to the blue-green region, resulting in poor penetration into tissues and strong autofluorescence interference. Moreover, most systems based on Si NPs are designed for single-function imaging or sensing, which limits their use in the delivery and treatment of tumortargeted drugs.
METHODS: Long wavelength fluorescent Si NPs with high physicochemical stability have been synthesised and incorporated into mesoporous silica nanoparticles (MSNs) for drug delivery. Chlorine e6 (Ce6) has been encapsulated as a photosensitizer. The resulting nanocomposites were coated with polydopamine (PDA) and functionalised with folic acid (FA) to realize active tumor-targeting capability.
RESULTS: The synthesized Si NPs showed stable long-wavelength fluorescence suitable for biological imaging. The FA-Si NPs-MSNs-PDA@Ce6 nanocomposite benefited from the FA-mediated targeting, increased permeability and retention effects and demonstrated increased tumor accumulation and cellular uptake. This strategy achieved tumor-specific fluorescence imaging, permitted real-time tracking of tumor cells, and boosted intracellular Ce6 delivery, thereby significantly elevating the photodynamic therapy (PDT) efficiency Discussion: This study presents a multifunctional nanoplatform that combines long-wave fluorescence imaging and pH-sensitive photodynamic therapy, thereby overcoming the significant limitations of traditional silicon nanoparticle-based systems. Targeted delivery and controlled release of drugs improve the accuracy of therapy and the effectiveness of imaging, and offer a promising strategy for tumor theranostics.
CONCLUSION: A multifunctional drug delivery nanoplatform based on Si NPs integrating targeted fluorescence imaging and photodynamic therapy has been successfully developed. This system holds great promise for tumor-targeted drug delivery and integrated theranostic applications.
METHODS: Long wavelength fluorescent Si NPs with high physicochemical stability have been synthesised and incorporated into mesoporous silica nanoparticles (MSNs) for drug delivery. Chlorine e6 (Ce6) has been encapsulated as a photosensitizer. The resulting nanocomposites were coated with polydopamine (PDA) and functionalised with folic acid (FA) to realize active tumor-targeting capability.
RESULTS: The synthesized Si NPs showed stable long-wavelength fluorescence suitable for biological imaging. The FA-Si NPs-MSNs-PDA@Ce6 nanocomposite benefited from the FA-mediated targeting, increased permeability and retention effects and demonstrated increased tumor accumulation and cellular uptake. This strategy achieved tumor-specific fluorescence imaging, permitted real-time tracking of tumor cells, and boosted intracellular Ce6 delivery, thereby significantly elevating the photodynamic therapy (PDT) efficiency Discussion: This study presents a multifunctional nanoplatform that combines long-wave fluorescence imaging and pH-sensitive photodynamic therapy, thereby overcoming the significant limitations of traditional silicon nanoparticle-based systems. Targeted delivery and controlled release of drugs improve the accuracy of therapy and the effectiveness of imaging, and offer a promising strategy for tumor theranostics.
CONCLUSION: A multifunctional drug delivery nanoplatform based on Si NPs integrating targeted fluorescence imaging and photodynamic therapy has been successfully developed. This system holds great promise for tumor-targeted drug delivery and integrated theranostic applications.